Rosen, trusted and top ranked investor counsel, encourages y-mabs therapeutics, inc. investors to secure counsel before important deadline in securities class action - ymab

New york, new york--(newsfile corp. - february 14, 2023) - why: rosen law firm, a global investor rights law firm, reminds purchasers of the securities of y-mabs therapeutics, inc. (nasdaq: ymab) between october 6, 2020 and october 28, 2022, both dates inclusive (the "class period"), of the important march 20, 2023 lead plaintiff deadline.
YMAB Ratings Summary
YMAB Quant Ranking